ASAPLAVIX, created in 2008 (France), from 2757 sister brands and 17477 competing brands. ASAPLAVIX is owned by Sanofi, listed on the stock exchange of Paris The International Securities Identification Number (ISIN) of Sanofi is FR0000120578. ASAPLAVIX belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Sanofi
(ASAPLAVIX)
over 5 years*
EUR 107.32